Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference

Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference

Targeting metabolic reprogramming is an emerging strategy in cancer therapy. However, clinical attempts to target metabolic reprogramming have been proved to be challenging, with metabolic heterogeneity of cancer being one of many reasons that causes treatment failure. Here, we stratified non-small...

ver descrição completa

Detalhes bibliográficos
Main Authors: Ting-Chun Kuo, Kuo-Yen Huang, Shuenn-Chen Yang, Sean Wu, Wei-Chia Chung, Yih-Leong Chang, Tse-Ming Hong, Shu-Ping Wang, Hsuan-Yu Chen, Tzu-Hung Hsiao, Pan-Chyr Yang
Formato: Artigo
Idioma:English
Publicado em: Elsevier 2020-09-01
Colecção:Molecular Therapy: Oncolytics
Assuntos:
NSCLC
cancer metabolism
metabolic heterogeneity
aerobic glycolysis
MCT4
Sp1
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2372770520300917

Registos relacionados

Registos relacionados